Stocks · Health care · Pharmaceutical Preparations

Karyopharm Therapeutics Inc.

KPTI Clue Score22
United States Fiscal year ends December CIK 0001503802 Results filed 13 Aug 2026

What the insiders did Net selling

By person

13 insiders · 21 transactions
0.1×

Richard Paulson holds only 0.1 times base salary in stock. $92.79K of shares against $770.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard Paulson last reported holding, valued at $0.34, the price Common Stock was last bought or sold at on the open market here, on 16 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Richard A. Paulson
President and CEO
—
$137.24K (2)
−$137.24K
269,747
$92.79K
+212.0%
Stuart Poulton
EVP, Chief Development Officer
—
$56.43K (4)
−$56.43K
94,632
$32.55K
+246.7%
Reshma Rangwala
EVP & Chief Medical Officer
—
$55.56K (3)
−$55.56K
56,829
$19.55K
+148.6%
Sohanya Roshan Cheng
EVP & Chief Commercial Officer
—
$46.40K (2)
−$46.40K
107,940
$37.13K
+276.3%
Michael Mano
EVP, CLO&Secretary
—
$35.70K (2)
−$35.70K
94,398
$32.47K
+417.1%
Lori Macomber
EVP, CFO & Treasurer
—
$10.24K (1)
−$10.24K
85,105
$29.28K
—
Kristin Abate
Chief Accounting Officer
—
$9.83K (7)
−$9.83K
18,616
$6.40K
+55.9%
Garen G Bohlin
Director
—
—
—
18,517
$6.37K
+515.4%
Barry E Greene
Director
—
—
—
16,415
$5.65K
+1,710%
Christy J. Oliger
Director
—
—
—
15,508
$5.33K
—
Deepika Pakianathan
Director
—
—
—
15,508
$5.33K
—
Zhen Su
Director
—
—
—
15,508
$5.33K
—
Chen Schor
Director
—
—
—
15,508
$5.33K
—

No percentages here. This company's share count has moved by a factor of 1,973.5 over the window, from 8,639,904 to 17,050,876,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.